Congratulations to John Rother of the National Coalition on Health Care, who wrote a great piece about 340B in Morning Consult on March 5. The 340B program, he says, gives safety-net hospitals and other providers “a safe haven” from the drug industry’s “worst overpricing practices.”
“The anti-340B campaign is fundamentally a means to distract lawmakers from the fact that current drug prices are unsustainable,” he writes. Read his complete essay here.
The National Coalition on Health Care takes the lead in the Campaign for Sustainable Rx Pricing, an umbrella group dedicated to finding market-based solutions to the problems caused by the onslaught of new high-priced prescription medicines. Before joining NHNC, Rother was an executive vice president of AARP.